According to previous studies, CX3CL1 and its unique CX3CR1 receptor are involved in the progress of PNI in pancreatic cancer cells (Hirth et al., 2020; Huang et al., 2020). This evidence concerns the gene CX3CL1 and familial pancreatic carcinoma.